Clinical trials
Obesity, Morbid trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| Istituto Auxologico Italiano | 4 |
| Catholic University of the Sacred Heart | 3 |
| University of Rome Tor Vergata | 2 |
| Fondazione Policlinico Universitario Campus Bio-Medico | 1 |
| IntraPace, Inc | 1 |
| Mario Musella MD | 1 |
| Ospedale V. Fazzi | 1 |
| Technische Universität Dresden | 1 |
| University of Campania Luigi Vanvitelli | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity, Morbid | 22 |
| Obesity | 6 |
| Metabolic Syndrome | 2 |
| Carcinoma, Hepatocellular | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Endometrial Neoplasms | 1 |
| Gastroesophageal Reflux | 1 |
| Genital Diseases, Female | 1 |
| Hypoglycemia | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.